NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 18,920
+250 (1.34%)
Aug 29, 2025, 12:41 PM KST
NeoPharm CO., LTD. Revenue
NeoPharm CO., LTD. had revenue of 31.98B KRW in the quarter ending June 30, 2025, with 4.44% growth. This brings the company's revenue in the last twelve months to 123.77B, up 14.75% year-over-year. In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B with 22.56% growth.
Revenue (ttm)
123.77B
Revenue Growth
+14.75%
P/S Ratio
2.36
Revenue / Employee
672.65M
Employees
172
Market Cap
292.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 119.01B | 21.91B | 22.56% |
| Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
| Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
| Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
| Dec 31, 2020 | 81.63B | -1.61B | -1.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KT&G Corporation | 6,231.77B |
| Samyang Foods | 1,999.91B |
| APR Co., Ltd. | 1,012.10B |
| Amorepacific | 4,141.44B |
| LG H&H | 6,626.30B |
| ORION | 3,215.62B |
| CJ Cheiljedang | 29.35T |
| Dong Suh Companies | 506.17B |